Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.

Kidney & blood pressure research - 1 Jan 2002

Reiterová Jana, Merta Miroslav, Tesar Vladimir, Stekrová Jitka

Abstract excerpt

BACKGROUND/AIM: The phenotypic variability of autosomal dominant polycystic kidney disease (ADPKD) cannot be explained only by various mutations of two known genes (PKD1 and PKD2), but the influence of other unknown factors should also be considered. Impairment of endothelial function has been observed in ADPKD patients. Our study tried to verify the hypothesis that endothelial nitric oxide synthase (ecNOS) gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Electrophoresis, Agar Gel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Introns

Share to Kidney Failure, Chronic

Share to Nitric Oxide

Share to Nitric Oxide Synthase

Share to Nitric Oxide Synthase Type III

Share to Polycystic Kidney, Autosomal Dominant

Source

Identifiers

PMID: 12077489
DOI: 10.1159/000063513

Genes

PKD1
PKD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.PMID 12077489Read ↗

Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.Semantic proximity Read ↗

Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseasesSemantic proximity Read ↗

The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Modifier effect of ENOS in autosomal dominant polycystic kidney diseaseSemantic proximity Read ↗

NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients.Semantic proximity Read ↗

Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease.Semantic proximity Read ↗

Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.Semantic proximity Read ↗

Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease.Semantic proximity Read ↗

Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.